The World Factbook CIA Home CIA Home About CIA Careers Offices of CIA News & Information Library TEEN?s Page Contact CIA CENTRAL INTELLIGENCE AGENCY

         

This page was last updated on 31 May, 2007


Map of Algeria




Bdi ii pdf:
Definition Field Listing
We use cookies to make interactions with our website easy and meaningful, to better understand the use of our services, and to tailor advertising. For further information, including about cookie settings, please read our Cookie Policy. By continuing to use this site, you consent to the use of cookies. Abstract Purpose Depression is highly prevalent in advanced cancer. moderate depression, and 29– 63 severe depression [ 29 ]. Patients were asked to fill out the questionnaire during their visit at the outpatient department or at home. The mood section of the PRIME-MD [ 30 ] was administered as. in a quick and simpl e way. The Beck Depression inventory (BDI-II) is one of the most widely used screening tools for depression and it may provide a useful method for screening for depression in palliative care [ 24– 26 ]. This inventory is a self-report. the participants originated from a heterogeneous group of patients with advanced cancer, whereas Katz et al. used a more homogeneous group of ambulatory head and neck cancer patients. Furthermore, Katz et al. used a different instrument, the Schedule for Affective Disorders and Schizophrenia, as a gold standard. A possible shortcoming of the BDI-II as a screening tool in advanced cancer patients is that the number of identified cases could be overestimated because of the somatic items of the questionnaire. The specific ity of the BDI-II in advanced cancer patients might be increased by excluding the somatic items (e.g., weight loss, loss of appetite, etc.). The Beck Depression Inventory Short Form (BDI-SF), consisting of seven items tapping exclusively affective symptoms, might be more appropriate for this popula tion. Love et al. performed a study in 227 women with met a gold standard for the clinical diagnosis of a depressive disorder by the physician, who was blind to the results of the questionnaire. The PRIME-MD is a structured interview based on the DSM-IV classification for depressive disorder and has been validated in oncology patients [ 31 ]. The. principles of advanced care planning that is promoted in patients with advanced cancer or in need of palliative care [ 21 ]. The ideal screening instrument comb ines a high. this population. Results From December 2003 until March 2007, 61 patients (29 men, 32 women) were eligible to be included in the study. The inclusion period of this study has been relatively long because the outpatient department for palliative care patients was a new facility in the hospital and, consequent- ly, referral numbers were low. Patients suffered from a variety of advanced cancers (23% colon carcinoma, 16% breast cancer, 8% head and neck cancer, 8% lung cancer, 45% some other malignancy). Of the 61 eligible patients, 20 patients (33%) deceased within 6 months. Seven eligible patients refused to participate in the study. Among the 54 patients who enrolled in the study, administra tion of the PRI ME-MD was not comp leted in eight patients (F ig. 1 ). Therefore, complete data were obtai ned of. 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com. tool. BDI-II Introduction Depression seems highly prevalent in patients with. ad- vanced cancer. In different studies, a large variation of prevalence of depression in advanced cancer (4% to 58%) is reported [ 1 ]. This large variation in prevalence can be. in this vulnerable patient group and the possibility to rule out depression in further diagnostic assessment in patients who screen positive for depression, a high sensitivity and high negative predictive value of screen- ing tools are important and a lower specificity and positive predictive value are accepted. The results of this study differ somewhat from previ ous findings on psychometric properties of the Beck Depression Inventory in a cancer patient sample. Katz et al. found that with a cut score of 16 the BDI had a sensi tivity of 73% and specificity of 100% in a sample of 60 ambulatory patients with a malignancy of t he head and neck region a nd identified the optimum cut score at 13 with a sensitivity of 92% and a specificity of 90% [ 32 ]. In the present study, Author content All content in this area was uploaded by Chris van Weel on Jan 03, 2016. Psychometric properties of single screening question and BDI-II. Depression is highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diagnosing depressive disorder in patients with advanced cancer. The aim of this study was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients. Patients with advanced metastatic disease, visiting the outpatient palliative care department, were asked to fill out a self-questionnaire containing the Beck Depression Inventory (BDI-II) and a single screening question "Are you feeling depressed?" The mood section of the PRIME-MD was used as a gold standard. Sixty-one patients with advanced metastatic disease were eligible to be included in the study. Complete data were obtained from 46 patients. The area under the curve of the receiver operating characteristics analysis of the BDI-II was 0.82. The optimal cut-off point of the BDI-II was 16 with a sensitivity of 90% and a specificity of 69%. The single screening question showed a sensitivity of 50% and a specificity of 94%. The BDI-II seems an adequate screening tool for a depressive disorder in advanced cancer patients. The sensitivity of a single screening question is poor. Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands C. Kan Department of Psychiatry, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands J. Prins Department of Medical Psychology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Support Care Cancer (2012) 20:319– 324 DOI 10.1007/s00520-010-1082-8. were eligible to be included in the study. Complete data were obtained from 46 patients. The area under the curve of the receiver operating characteristics analysis of the BDI-II was 0.82. The optimal cut-off point of the BDI-II was 16 with a sensitivity of 90% and a specificity of 69%. The single screening question showed a sensitivity of 50% and a specificity of 94%. Conclusions The BDI-II seems an adequate screening tool. physician emotional issues are difficult to address in this phase of life. Only a minority (17%) of advanced. follows: 0– 13 no depression, 14– 19 mild depression, 20– 28. patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diagnosing depressive disorder in patients with advanced cancer. The aim of this st udy was to determine the validity of the Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in advanced cancer patients. Methods Patients with advanced metastatic disease, visi ting. BDI-II demonstrated 90% sensitivity and 64% specificity. The positive and negative predictive values were 45% and 97%, respectively. However, using a. /Annots[ 9 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group /Tabs/S/StructParents 0>> endobj 4 0 obj. )/Type/Annot/AP >> endobj 95 0 obj >> endobj 96 0 obj [] endobj 97 0 obj [94 0 R] endobj 100 0 obj. Richter, P; J Werner; A Heerlein; A Kraus; H Sauer (1998). "On the validity of the Beck Depression Inventory. A review". The BDI-II was a 1996 revision of the BDI, [9]. The development of the BDI reflects that in its structure, with items such as "I have lost all of my interest in other people" to reflect the world, "I feel discouraged about the future" to reflect the future, and "I blame myself for everything bad that happens" to reflect the self. The view of depression as sustained by intrusive negative cognitions has had particular application in cognitive behavioral therapy (CBT), which aims to challenge and neutralize them through techniques such as cognitive restructuring. and public domain scales such as the Patient Health Questionnaire– Nine Item ( PHQ-9 ) have been studied as a useful tool. [22]. This page was last edited on 4 April 2019, at 09:02 (UTC). Zimmerman M. Using scales to monitor symptoms and treatment of depression (measurement based care). In UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2011. The Beck Depression Inventory ( BDI, BDI-1A, BDI-II ), created by Aaron T. Beck, is a 21-question multiple-choice. Beck AT, Steer RA and Brown GK (1996) "Manual for the Beck Depression Inventory-II". San Antonio, TX: Psychological Corporation. JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. The internal consistency for the BDI-IA was good, with a Cronbach's alpha coefficient of around 0.85, meaning that the items on the inventory are highly correlated with each other. [10]. We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the. "Literature available on Psychiatric Assessment Instruments translated in non-English languages: TBDI Section". Victorian Transcultural Psychiatry Unit. December 2005. Archived from the original on July 19, 2008. Retrieved 2009-02-24. However, this version retained some flaws; the BDI-IA only addressed six out of the nine DSM-III criteria for depression. This and other criticisms were addressed in the BDI-II. The BDI was used as a model for the development of the TEENren's Depression Inventory (CDI), first published in 1979 by clinical psychologist Maria Kovacs. [2]. The student has negative thoughts about the world, so he may come to believe he does not enjoy the class. The student has negative thoughts about his self, as he may feel he does not deserve to be in college. [5]. Some items on the original BDI had more than one statement marked with the same score. For instance, there are two responses under the Mood heading that score a 2: (2a) "I am blue or sad all the time and I can't snap out of it" and (2b) "I am so sad or unhappy that it is very painful". [1]. Like the BDI, the BDI-II also contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used differ from the original: Brown GP, Hammen CL, Craske MG, Wickens TD (August 1995). "Dimensions of dysfunctional attitudes as vulnerabilities to depressive symptoms". Journal of Abnormal Psychology. 104 (3): 431–5. doi: 10.1037/0021-843X.104.3.431. PMID. Bowling A (September 2005). "Mode of questionnaire administration can have serious effects on data quality". Journal of public health (Oxford, England). 27 (3): 281–91. doi: 10.1093/pubmed/fdi031. PMID. Higher total scores indicate more severe depressive symptoms. Sorry, preview is currently unavailable. You can download the paper by clicking the button above.